Intersect ENT
XENT
#6270
Rank
A$1.43 B
Marketcap
A$42.41
Share price
0.00%
Change (1 day)
14.74%
Change (1 year)

Earnings for Intersect ENT (XENT)

Earnings in 2021: -A$0.25 Billion

According to Intersect ENT's latest financial reports the company's current earnings are A$0.10 Billion. In 2021 the company made an earning of -A$0.25 Billion a decrease over its 2020 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intersect ENT from 2012 to 2021

Annual earnings

Year Earnings Change
2021-A$0.25 Billion121.8%
2020-A$0.11 Billion69.17%
2019-A$64.58 Million87.57%
2018-A$34.43 Million40.08%
2017-A$24.58 Million-35.12%
2016-A$37.89 Million-5.3%
2015-A$40.01 Million45.05%
2014-A$27.58 Million-0.04%
2013-A$27.59 Million12.25%
2012-A$24.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ocular Therapeutix
OCUL
-A$0.46 Billion 86.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
A$0.35 B-247.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
-A$7.7 Million-96.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.26 B-209.68%๐Ÿ‡บ๐Ÿ‡ธ USA